These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18540886)
21. RhoA induces expression of inflammatory cytokine in adipocytes. Nakayama Y; Komuro R; Yamamoto A; Miyata Y; Tanaka M; Matsuda M; Fukuhara A; Shimomura I Biochem Biophys Res Commun; 2009 Feb; 379(2):288-92. PubMed ID: 19101507 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats. Liu M; Gu M; Wu Y; Zhu P; Zhang W; Yin C; Zhang WJ J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538 [TBL] [Abstract][Full Text] [Related]
23. Integrin α3 blockade enhances microtopographical down-regulation of α-smooth muscle actin: role of microtopography in ECM regulation. Ayala P; Desai TA Integr Biol (Camb); 2011 Jul; 3(7):733-41. PubMed ID: 21666923 [TBL] [Abstract][Full Text] [Related]
24. Development of Rho-kinase inhibitors for cardiovascular medicine. Shimokawa H; Rashid M Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681 [TBL] [Abstract][Full Text] [Related]
25. Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases. Enkvist E; Lavogina D; Raidaru G; Vaasa A; Viil I; Lust M; Viht K; Uri A J Med Chem; 2006 Nov; 49(24):7150-9. PubMed ID: 17125267 [TBL] [Abstract][Full Text] [Related]
26. Control of basement membrane remodeling and epithelial branching morphogenesis in embryonic lung by Rho and cytoskeletal tension. Moore KA; Polte T; Huang S; Shi B; Alsberg E; Sunday ME; Ingber DE Dev Dyn; 2005 Feb; 232(2):268-81. PubMed ID: 15614768 [TBL] [Abstract][Full Text] [Related]
27. [Rho-kinase signaling pathway participates in endothelin-1-induced human airway smooth muscle cell migration and cytoskeletal reorganization]. Li ZX; Luo YL; Xu J; Ren DQ; Zhao YX Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1031-4. PubMed ID: 18583257 [TBL] [Abstract][Full Text] [Related]
28. Myosin light chains are not a physiological substrate of AMPK in the control of cell structure changes. Bultot L; Horman S; Neumann D; Walsh MP; Hue L; Rider MH FEBS Lett; 2009 Jan; 583(1):25-8. PubMed ID: 19061891 [TBL] [Abstract][Full Text] [Related]
29. Phytate hydrolysate induces circumferential F-actin ring formation at cell-cell contacts by a Rho-associated kinase-dependent mechanism in colorectal cancer HT-29 cells. Suzuki T; Hara H Mol Nutr Food Res; 2010 Dec; 54(12):1807-18. PubMed ID: 20626001 [TBL] [Abstract][Full Text] [Related]
30. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts. Akhmetshina A; Dees C; Pileckyte M; Szucs G; Spriewald BM; Zwerina J; Distler O; Schett G; Distler JH Arthritis Rheum; 2008 Aug; 58(8):2553-64. PubMed ID: 18668558 [TBL] [Abstract][Full Text] [Related]
32. Diphosphorylation of regulatory light chain of myosin IIA is responsible for proper cell spreading. Hirata N; Takahashi M; Yazawa M Biochem Biophys Res Commun; 2009 Apr; 381(4):682-7. PubMed ID: 19254691 [TBL] [Abstract][Full Text] [Related]
33. Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase. Viht K; Schweinsberg S; Lust M; Vaasa A; Raidaru G; Lavogina D; Uri A; Herberg FW Anal Biochem; 2007 Mar; 362(2):268-77. PubMed ID: 17274940 [TBL] [Abstract][Full Text] [Related]
34. Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Rösel D; Brábek J; Tolde O; Mierke CT; Zitterbart DP; Raupach C; Bicanová K; Kollmannsberger P; Panková D; Vesely P; Folk P; Fabry B Mol Cancer Res; 2008 Sep; 6(9):1410-20. PubMed ID: 18819929 [TBL] [Abstract][Full Text] [Related]
35. High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK. Vaasa A; Viil I; Enkvist E; Viht K; Raidaru G; Lavogina D; Uri A Anal Biochem; 2009 Feb; 385(1):85-93. PubMed ID: 19017524 [TBL] [Abstract][Full Text] [Related]
36. Y-39983, a selective Rho-kinase inhibitor, attenuates experimental autoimmune encephalomyelitis via inhibition of demyelination. Gao C; Huang L; Long Y; Zheng J; Yang J; Pu S; Xie L Neuroimmunomodulation; 2013; 20(6):334-40. PubMed ID: 24008512 [TBL] [Abstract][Full Text] [Related]
37. Participation of Rho-associated kinase in electrical stimulated and acetylcholine-induced contraction of feline esophageal smooth muscle. Park SY; Song HJ; Sohn UD Eur J Pharmacol; 2009 Apr; 607(1-3):220-5. PubMed ID: 19239907 [TBL] [Abstract][Full Text] [Related]
38. [The effect of Rho-kinase inhibition depends on the nature of factors that modify endothelial permeability]. Smurova KM; Verin AD; Alieva IB Tsitologiia; 2011; 53(4):359-66. PubMed ID: 21675216 [TBL] [Abstract][Full Text] [Related]
39. Prostanoid F receptors elicit an inotropic effect in rat left ventricle by enhancing myosin light chain phosphorylation. Riise J; Nguyen CH; Qvigstad E; Sandnes DL; Osnes JB; Skomedal T; Levy FO; Krobert KA Cardiovasc Res; 2008 Dec; 80(3):407-15. PubMed ID: 18703533 [TBL] [Abstract][Full Text] [Related]
40. Bisubstrate inhibitors of protein kinases: from principle to practical applications. Lavogina D; Enkvist E; Uri A ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]